Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure

Critical Care

Volumn 14, Issue 3, 2010, Pages

  Mayeur, Nicolas ^a   Rostaing, Lionel ^b   Nogier, Marie B ^b   Jaafar, Acil ^b   Cointault, Olivier ^b   Kamar, Nassim ^b   Conil, Jean M ^a   Fourcade, Olivier ^a   Lavayssiere, Laurence ^b  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYSTATIN C; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NORADRENALIN; BIOLOGICAL MARKER; CYTOKINE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; ARTIFICIAL KIDNEY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; KINETICS; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; BLOOD; GLOMERULUS FILTRATION RATE; MIDDLE AGED; PHYSIOLOGY;

ACUTE KIDNEY INJURY; AGED; BIOLOGICAL MARKERS; CYSTATIN C; CYTOKINES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SHOCK, SEPTIC;

EID: 77953353925     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9064     Document Type: Article

References (36)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333, 12519925.
3. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891. 10.1038/nature01326, 12490963.
4. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002, 62:986-996. 10.1046/j.1523-1755.2002.00509.x, 12164882.
5. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65:1357-1365. 10.1111/j.1523-1755.2004.00512.x, 15086475.
6. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007, 167:1655-1663. 10.1001/archinte.167.15.1655, 17698689.
7. Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005, 23:488-493.
8. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998, 351:950-953.
9. Schmidt C, Hocherl K, Schweda F, Bucher M. Proinflammatory cytokines cause down-regulation of renal chloride entry pathways during sepsis. Crit Care Med 2007, 35:2110-2119. 10.1097/01.ccm.0000281447.22966.8b, 17855824.
10. Ziegler EJ, Fisher CJ, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: a randomized, double-blind, placebo-controlled trial: the HA-1A Sepsis Study Group. N Engl J Med 1991, 324:429-436. 10.1056/NEJM199102143240701, 1988827.
11. Fisher CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein: the Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996, 334:1697-1702. 10.1056/NEJM199606273342603, 8637514.
12. Warren HS. Strategies for the treatment of sepsis. N Engl J Med 1997, 336:952-953. 10.1056/NEJM199703273361311, 9070479.
13. De Vriese AS, Vanholder RC, Pascual M, Lameire NH, Colardyn FA. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?. Intensive Care Med 1999, 25:903-910. 10.1007/s001340050981, 10501744.
14. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28:3581-3587. 10.1097/00003246-200011000-00001, 11098957.
15. Haase M, Bellomo R, Baldwin I, Haase-Fielitz A, Fealy N, Davenport P, Morgera S, Goehl H, Storr M, Boyce N, Neumayer HH. Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. Am J Kidney Dis 2007, 50:296-304. 10.1053/j.ajkd.2007.05.003, 17660031.
16. Leblanc M, Charbonneau R, Lalumiere G, Cartier P, Deziel C. Postdialysis urea rebound: determinants and influence on dialysis delivery in chronic hemodialysis patients. Am J Kidney Dis 1996, 27:253-261. 10.1016/S0272-6386(96)90549-1, 8659502.
17. Alloatti S, Molino A, Manes M, Bosticardo GM. Urea rebound and effectively delivered dialysis dose. Nephrol Dial Transplant 1998, 13(Suppl 6):25-30. 10.1093/ndt/13.suppl_6.25, 9719200.
18. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR: history, indications, and future research. Clin Biochem 2005, 38:1-8. 10.1016/j.clinbiochem.2004.09.025, 15607309.
19. Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB. Biomarkers of acute renal injury and renal failure. Shock 2006, 26:245-253. 10.1097/01.shk.0000225415.5969694.ce, 16912649.
20. Mulay A, Biyani M, Akbari A. Cystatin C and residual renal function in patients on peritoneal dialysis. Am J Kidney Dis 2008, 52:194-195. author reply, 195-196, 10.1053/j.ajkd.2008.04.022, 18589221.
21. Hoek FJ, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant 2007, 22:1633-1638. 10.1093/ndt/gfm027, 17403704.
22. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
23. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212. 10.1186/cc2872, 522841, 15312219.
24. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30:536-555. 10.1007/s00134-004-2398-y, 14997291.
25. Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, Lemaire F, Brochard L. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med 2000, 162:197-202.
26. Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, Hirasawa H. Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med 2008, 14:257-263. 10.2119/2007-00108.Nakada, 2263139, 18327291.
27. Galli F, Benedetti S, Floridi A, Canestrari F, Piroddi M, Buoncristiani E, Buoncristiani U. Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers. Kidney Int 2005, 67:750-759. 10.1111/j.1523-1755.2005.67138.x, 15673326.
28. Ishikawa I, Chikazawa Y, Sato K, Nakagawa M, Imamura H, Hayama S, Yamaya H, Asaka M, Tomosugi N, Yokoyama H, Matsumoto K. Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and PMMA) during hemodialysis treatment using SELDI-TOF-MS. Am J Nephrol 2006, 26:372-380. 10.1159/000094779, 16873993.
29. Aucella F, Vigilante M, Gesuete A, Maruccio G, Specchio A, Gesualdo L. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?. Nephrol Dial Transplant 2007, 22(Suppl 5):v8-v12. 10.1093/ndt/gfm293, 17586845.
30. Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol 2007, 18:886-895. 10.1681/ASN.2006080821, 17229909.
31. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11:R49. 10.1186/cc5783, 2206478, 17448250.
32. Ronco C, Brendolan A, Bellomo R. Online monitoring in continuous renal replacement therapies. Kidney Int Suppl 1999, S8-14. 10.1046/j.1523-1755.56.s72.11.x, 10560797.
33. Stein B, Pfenninger E, Grunert A, Schmitz JE, Hudde M. Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990, 16:494-499. 10.1007/BF01709399, 2286729.
34. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992, 18:235-240. 10.1007/BF01709839, 1430589.
35. Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997, 23:288-296. 10.1007/s001340050330, 9083231.
36. Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol 2002, 15:150-157.